In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV Ribonuclease H Inhibitors
Author:
Li Qilan,Tavis John E.
Reference22 articles.
1. Seeger C, Zoulim F, Mason WS (2021) Hepadnaviridae. In: Fields virology, vol 2: DNA viruses. Wolters Kluwer, Philadelphia, pp 640–682 2. Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403–415 3. Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R, Members of the ICE-HBV Working Groups, Chairs of the ICE-HBV Stakeholders Groups, Senior Advisors to ICE-HBV, Zoulim F (2019) A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol 4:545–558. https://doi.org/10.1016/S2468-1253(19)30119-0 4. Trepo C, Chan HL, Lok A (2014) Hepatitis B virus infection. Lancet 384(9959):2053–2063. https://doi.org/10.1016/S0140-6736(14)60220-8 5. Polaris Observatory Collaborators (2018) Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol 3(6):383–403. https://doi.org/10.1016/S2468-1253(18)30056-6
|
|